In contrary to Sham group that showed an undetectable amount of IL-1β by immunoassay, colitis control group expressed a higher colonic level of IL-1β and the anti-inflammatory effects of dizocilpine (1 mg/kg) was confirmed by a significant decrease in IL-1β levels in comparison to the colitis control (P < 0.05). Here, IL1B is linked to colitis.